Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Nuclear pore associated protein 1 pseudogene 4 (NPAP1P4) is annotated as a pseudogene derived from the nuclear pore associated protein 1 gene family. Pseudogenes are nonfunctional DNA sequences that resemble genes but have been rendered inactive by mutations, deletions, or duplications[6]. While some pseudogenes have roles in gene regulation—such as acting as microRNA decoys or generating small interfering RNAs—this has not been established for NPAP1P4 in scientific literature[2][4]. NPAP1P4 does not produce a protein product and is not implicated in diseases or therapeutic contexts. Therefore, it is not considered a canonical molecular target in pharmacology or molecular medicine.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Nuclear pore associated protein 1 pseudogene 4 (NPAP1P4).